194 related articles for article (PubMed ID: 21619428)
1. Transcriptional regulation and pharmacogenomics.
Georgitsi M; Zukic B; Pavlovic S; Patrinos GP
Pharmacogenomics; 2011 May; 12(5):655-73. PubMed ID: 21619428
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny and drug metabolism in newborns.
Dotta A; Chukhlantseva N
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of the OATP and OAT families.
Marzolini C; Tirona RG; Kim RB
Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and the future of toxicology testing.
Agrawal YP; Rennert H
Clin Lab Med; 2012 Sep; 32(3):509-23. PubMed ID: 22939305
[TBL] [Abstract][Full Text] [Related]
5. Development of a broad-based ADME panel for use in pharmacogenomic studies.
Brown AM; Renaud Y; Ross C; Hansen M; Mongrain I; Valois D; Carleton BC; Hayden MR; Dubé MP; Tardif JC; Phillips MS
Pharmacogenomics; 2014 Jun; 15(9):1185-95. PubMed ID: 25141894
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.
Johnson AD; Wang D; Sadee W
Pharmacol Ther; 2005 Apr; 106(1):19-38. PubMed ID: 15781120
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and personalized medicine.
Tang J; Xiong Y; Zhou HH; Chen XP
J Clin Pharm Ther; 2014 Dec; 39(6):621-7. PubMed ID: 25230364
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
Evans WE; Johnson JA
Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
[TBL] [Abstract][Full Text] [Related]
10. Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters.
Kim V; Wal TV; Nishi MY; Montenegro LR; Carrilho FJ; Hoshida Y; Ono SK
Pharmacogenomics; 2020 Jun; 21(9):575-586. PubMed ID: 32486903
[No Abstract] [Full Text] [Related]
11. Population genetic structure of variable drug response.
Wilson JF; Weale ME; Smith AC; Gratrix F; Fletcher B; Thomas MG; Bradman N; Goldstein DB
Nat Genet; 2001 Nov; 29(3):265-9. PubMed ID: 11685208
[TBL] [Abstract][Full Text] [Related]
12. Comparative and veterinary pharmacogenomics.
Mosher CM; Court MH
Handb Exp Pharmacol; 2010; (199):49-77. PubMed ID: 20204583
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
Rukov JL; Shomron N
Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
[TBL] [Abstract][Full Text] [Related]
14. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
Trent RJ; Cheong PL; Chua EW; Kennedy MA
Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
[TBL] [Abstract][Full Text] [Related]
15. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and pharmacogenomics.
Shomron N
Pharmacogenomics; 2010 May; 11(5):629-32. PubMed ID: 20415550
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism tagging set for human drug metabolism and transport.
Ahmadi KR; Weale ME; Xue ZY; Soranzo N; Yarnall DP; Briley JD; Maruyama Y; Kobayashi M; Wood NW; Spurr NK; Burns DK; Roses AD; Saunders AM; Goldstein DB
Nat Genet; 2005 Jan; 37(1):84-9. PubMed ID: 15608640
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
19. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).
Ishikawa T; Sakurai A; Hirano H; Lezhava A; Sakurai M; Hayashizaki Y
Pharmacol Ther; 2010 Apr; 126(1):69-81. PubMed ID: 20138191
[TBL] [Abstract][Full Text] [Related]
20. DrugBank and its relevance to pharmacogenomics.
Wishart DS
Pharmacogenomics; 2008 Aug; 9(8):1155-62. PubMed ID: 18681788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
